Wintrust Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Wintrust Investments’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,210	Closed	-$205K	–	397
2022 Q2	$205K	Hold	3,210	–	–	0.02%	359
2022 Q1	$208K	Hold	3,210	–	–	0.02%	388
2021 Q4	$214K	Sell	3,210 -1,023	-24%	-$64.9K	0.02%	396
2021 Q3	$258K	Buy	+4,233	New	+$269K	0.03%	238

Other funds holding IHE

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wintrust Investments's IHE Position: Q3 2022 in Review

Wintrust Investments sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2022, closing a stake of 3,210 shares — an estimated $205K sold.

Wintrust Investments first reported a position in IHE in Q3 2021 and held it in 4 quarters. The position peaked at $258K in Q3 2021. 113 funds tracked by Wall St. Rank hold IHE as of Q3 2022.

Wintrust Investments reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
Wintrust Investments sold 3,210 iShares US Pharmaceuticals ETF shares in Q3 2022, an estimated $205K.
Wintrust Investments first reported a position in iShares US Pharmaceuticals ETF in Q3 2021 and held it in 4 quarters.
Wintrust Investments's iShares US Pharmaceuticals ETF position peaked at $258K in Q3 2021.
113 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2022.

Based on Wintrust Investments's 13F filing for Q3 2022, filed 9 Nov 2022.